Target Information

Target General Infomation
Target ID
T51883
Target Name
Raf protein kinase
Target Type
Clinical Trial
Disease Cancer [ICD9: 140-229; ICD10: C00-C96]
BioChemical Class
Transferases (EC:2)
EC Number
EC 2.7.11.1
Drugs and Mode of Action
Drug(s) LY3009120 Drug Info Phase 1 Cancer [524570]
RO-5126766 Drug Info Phase 1 Cancer [525139]
Modulator LY3009120 Drug Info
RO-5126766 Drug Info
References
Ref 524570ClinicalTrials.gov (NCT02014116) A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body. U.S. National Institutes of Health.
Ref 525139ClinicalTrials.gov (NCT02407509) Phase I Trial of RO5126766. U.S. National Institutes of Health.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.